Clinical Trial Update: Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating pain modulation strategies for gastroesophageal reflux disease in patients who failed standard-dose proton pump inhibitor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Gastroesophageal Reflux Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-08-18